awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33398716-3C4ADFB3-37EB-4AB5-B8B3-0BA28A151B1C
Q33398716-3C4ADFB3-37EB-4AB5-B8B3-0BA28A151B1C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33398716-3C4ADFB3-37EB-4AB5-B8B3-0BA28A151B1C
Dasatinib or imatinib in newly diagnosed chronic-phase chronic myeloid leukemia: 2-year follow-up from a randomized phase 3 trial (DASISION).
P2860
Q33398716-3C4ADFB3-37EB-4AB5-B8B3-0BA28A151B1C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33398716-3C4ADFB3-37EB-4AB5-B8B3-0BA28A151B1C
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
70ea8e210af34c6411d5127994a1b7f507d6f4ac
P2860
Delayed achievement of cytogenetic and molecular response is associated with increased risk of progression among patients with chronic myeloid leukemia in early chronic phase receiving high-dose or standard-dose imatinib therapy